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Abstract. Beginning in 2014, there has been significant progress in normalization of relations between Cuba
and the United States. Herein, we discuss the history and recent progress in scientific collaboration between the
two countries as well as the continued challenges. Science and global health diplomacy can be key tools in
reestablishing a trusting and productive relationship of mutual and global benefit, bringing about better and healthier
lives for people in both Cuba and the United States.
On December 17, 2014, U.S. President Barack Obama
and Cuban President Raúl Castro announced the begin-
ning of a process of normalizing relations, now commonly
referred to as the “Cuban Thaw.”
On July 20, 2015, the two countries restored diplomatic
relations, which had been severed in 1961 during the Cold
War. This was followed in March 2016 by Obama’s historic
visit to the island—the first official visit of a U.S. president
since the 1959 Cuban revolution. In December and also
during his visit, Obama highlighted health as one of the
shared priorities of the two governments. These events
renewed optimism among many observers that the two
nations, long estranged but only 90 miles apart, can con-
tinue to work together on many fronts, but especially in
the domains of science and global health, which in and
of themselves can serve as effective tools to normalize
the relationship.
The American Society of Tropical Medicine and Hygiene
(ASTMH) has contributed to this renewed engagement by
bringing Cuban and American scientists together at the
Society’s 20151 and 20162 annual meetings to present on
the many scientific advances coming from Cuba, continued
challenges, and what the future can bring if the two coun-
tries can rekindle their history of cooperation in science
and global health. A symposium at the 2015 meeting in
Philadelphia was cosponsored by the Pan American Health
Organization (PAHO) with participation from members of
the U.S. National Institutes of Health (NIH) and U.S. Depart-
ment of Health and Human Services (HHS). Immediately
after the ASTMH Meeting, a dinner was held in Washington,
DC, hosted by the Center for Strategic and International
Studies, at which representatives from the U.S. State
Department, HHS, Uniformed Services University of the
Health Sciences, PAHO, NIH, and ASTMH welcomed the
Cuban visitors and eagerly discussed the potential of new
collaborations. The next day the delegation visited the NIH
in Bethesda, MD, the first visit by Cuban scientists to NIH in
more than 50 years. ASTMH members also participated in
a virology workshop organized by the Cuban Society of
Microbiology and Parasitology in Havana in December
20163 and the Society will cosponsor a scientific conference
commemorating the 80th anniversary of Cuba’s premier
institute for tropical medicine, the Instituto Pedro Kourí, in
Havana in December 2017.
Bilateral cooperation in science and global health
between Cuba and the United States makes sense. Our
geographical proximity means that we share waters and
are affected by the same environmental factors, the same
tropical storms, and many of the same health challenges.
The United States and Cuba share an obvious interest
in detecting and responding to emerging infectious dis-
eases such as dengue, chikungunya, and Zika fevers,
which are growing rapidly in the region and for which no
vaccines currently exist. As travel and business opportu-
nities grow between the two countries, so will the risk
of transfer of pathogens. Mitigating that risk will require
intensified collaboration and investment of resources. In
addition, both countries have aging populations, necessi-
tating an increased focus on biomedical research and
health services for cardiac diseases, cancer, diabetes,
and neurodegenerative diseases such as Parkinson’s and
Alzheimer’s diseases.
Beyond their physical proximity, Cuba and the United
States share a dedication to scientific inquiry and discov-
ery. Despite having different health systems and priorities,
both countries are proud of their scientific accomplish-
ments and advances in public health. Cuba reports one
of the lowest infant mortality rates in the world and a life
expectancy on par with the United States. In 2014, Cuba
became the first country to eliminate mother-to-child trans-
mission of human immunodeficiency virus and syphilis.
Cuba is one of the few countries without a shortage of
human resources for health. They have ample numbers of
trained medical personnel and have offered clinical sup-
port to respond to emergencies and assist with the imple-
mentation of health programs in more than 100 countries.
Heberprot-P, a Cuban medication licensed in more than
20 countries, reduces risk for limb amputation among
patients with diabetes by 70%. Early studies on CIMAVax,
an experimental immunotherapeutic agent for lung cancer
developed by the Cuban Center for Molecular Immunol-
ogy in Havana, have indicated a survival benefit as well
as improved quality of life. Products such as these could
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provide enormous health benefit to the U.S. population
but have not generally been available for use in the
United States. For example, in any given year, nearly
80,000 patients with diabetes in the United States
undergo amputation at a cost of approximately $50 billion.4
Heberprot-P could potentially be of enormous benefit to
these patients.
U.S. accomplishments in health and the biomedical sci-
ences are widely acclaimed. The NIH is the world’s largest
funder of medical research and has the largest hospital
dedicated solely to clinical research. NIH-funded research
led to the development of magnetic resonance imaging
technology, an understanding of how viruses can cause
cancer, insights into cholesterol control, and knowledge of
how our brain processes visual information, among many
other advances. The U.S. Centers for Diseases Control
and Prevention has established the Global Disease Detec-
tion Program with regional centers throughout the world
that have responded to outbreaks of anthrax in Scotland,
botulism in Thailand, cholera in Haiti, Ebola in west Africa,
and dozens more.
The strengths and accomplishments of Cuba and the
United States in the health sciences complement each
other. Not surprisingly, some of the two countries’ greatest
health achievements have resulted from working together.
At the turn of the 20th century, Cuban and American scien-
tists such as Carlos Finlay and Walter Reed collaborated
to unravel the mystery of yellow fever, confirming Finlay’s
theory of mosquito-borne transmission and promoting
evidence-based control modalities. Over the years, deter-
mined Cuban and U.S. government scientists have found
ways to engage, albeit limited and through a heavy layer
of regulatory red tape, on a number of scientific research
collaborations, including in the fields of health (such as
infectious diseases, antimicrobial drug resistance, neuro-
science, cancer, and migrant health), marine science, ecol-
ogy and conservation, and atmospheric and geoscience
research. In 2014, a Cuban brigade of more than 400 doc-
tors and nurses staffed an Ebola Treatment Unit funded by
the U.S. Agency for International Development in Monrovia,
Liberia, helping to control the outbreak of Ebola virus dis-
eases in West Africa. Cuban and U.S. physicians have
also recently worked together on emergency responses in
the aftermath of Hurricane Matthew in Haiti, with Cuban
physicians working on the USNS Comfort, a U.S. Navy
hospital ship that sailed to Port-au-Prince to provide free
medical care.
Cracks in the long-standing barriers to scientific collabo-
ration between Cuba and the United States are starting to
occur. In June 2015, the HHS sent three participants to
Cuba on the first government-led delegation on health and
science. In October 2016, former HHS Secretary Sylvia
Burwell traveled to Cuba, where she signed a Memorandum
of Understanding on cancer control and explored additional
opportunities for collaboration. Also in October 2016,
the U.S. Departments of the Treasury and of Commerce
announced amendments to the Cuban asset control reg-
ulations. These changes will facilitate the movement of
Cuban-origin pharmaceutical applications through the U.S.
Food and Drug Administration (FDA) review process and
allow FDA-approved Cuban-origin pharmaceuticals to be
imported, marketed, and sold in the United States. In 2016,
the FDA approved the first clinical trial of a Cuban drug in
the United States—a Phase I/II clinical trial of CIMAVax. For
its part, Cuba may benefit from broader engagement with
U.S. biomedical and research communities who may, for
example, provide the latest data and biotechnological
advances for optimal clinical management of diseases
Cuban clinicians may encounter as part of the many Cuban
medical brigades overseas. A meeting between NIH and
Cuban scientists to coordinate the public health response
to and research on Zika virus disease was held in Havana
in November 2016. Nongovernmental entities, including
academic institutions and professional societies such as
ASTMH, have stepped in to play a unique role in improv-
ing Cuba–U.S. relations, including facilitation of educational
exchanges for students and faculty.
The recent steps toward normalization of relations are
promising, but many questions and challenges remain.
Nothing between the two countries is easily separable from
politics. Trust needs to be built, not taken for granted.
Recent political changes in the United States bring new
questions over the thaw’s future. Will President Trump con-
tinue the easing of trade and travel started by Obama? Will
Cuba’s policy toward the United States alter with a new
generation of leaders in coming years? Leadership in Cuba
will inevitably give way to a new generation. As that change
takes place, the United States must address whether to
continue the trade embargo, which has been in place since
1960. Despite legislation signed by President Clinton in
2000 creating limited exceptions for medical supplies and
devices, the embargo remains a major impediment to nor-
malization of relations and more advanced scientific devel-
opment for both countries.
While elected leadership may remain split on the way for-
ward, public sentiment is softening. In recent polls, 62% of
Americans said they favored normalizing relations with
Cuba and lifting the embargo.5 Lifting the embargo was
favored by 63% of Cuban-Americans in Miami-Dade
County, FL, the area with the highest concentration of
Cuban Americans in the United States.6 The sentiment for
normalization of relations in Cuba itself is hard to gauge.
Obama’s actions in that regard over the past few years
appear to have been generally welcomed by the populace,
albeit with concerns over how Cuba can integrate into and
benefit from a more global economic engagement without
sacrificing many of its fundamental principles and public
health achievements.
Advancing political understanding between Cuba and
the United States will require high-level political will and
leadership, cross-border partnerships, and sustained advo-
cacy. Science and global health diplomacy are key tools
in reestablishing a trusting and productive relationship of
mutual and global benefit. Health has a universal appeal,
with the potential not only to transcend politics, but to pro-
mote and advance constructive political discourse. The
exchange of data and views at recent scientific conferences
in Cuba and United States was a great place to start. As
Cuban and American scientists, clinicians, and experts in
global health, we must continue our dialogue and advocacy
to keep open our communications and collaborations and to
keep moving forward. We recognize that we have much to
teach, learn, and gain from each other. It is our fervent hope
that the political discourse continues to intensify in a positive
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direction to unlock the potential of Cuban and American
science to bring about better and healthier lives for people in
both countries.
Received February 20, 2017. Accepted for publication February
25, 2017.
Published online May 1, 2017.
Acknowledgments: We thank Lara Schwarz, Mikiko Senga, and
Thomas Watkins for critical review of the manuscript.
Disclaimer: The views expressed in this article are those of the
authors and do not necessarily reflect the official policy or position
of the Pan American Health Organization.
Authors’ addresses: Daniel G. Bausch, American Society of Tropi-
cal Medicine and Hygiene, Oakbrook Terrace, IL, and Tulane
School of Public Health and Tropical Medicine, New Orleans, LA,
E-mail: daniel.bausch@lshtm.ac.uk. Maria G. Guzman, Virology
Department, WHO Collaborating Center for Viral Diseases, Instituto
de Medicina Tropical Pedro Kourí, Havana, Cuba, E-mail: lupe@ipk.
sld.cu. Vivian Kouri, Sonia Resik, and Belsy Acosta, Instituto de
Medicina Tropical Pedro Kourí, Havana, Cuba, E-mails: vkouri@ipk.
sld.cu, sresik@ipk.sld.cu, and betsy@ipk.sld.cu. Gerardo Guillen,
Centro de Ingenieria Genetica y Biotecnologia, Havana, Cuba,
E-mail: gerardo.guillen@cigb.edu.cu. Karen Goraleski, American
Society of Tropical Medicine and Hygiene, Oakbrook Terrace, IL,
E-mail: kgoraleski@astmh.org. Marcos Espinal, Pan American
Health Organization, Washington, DC, E-mail: espinalm@paho.org.
This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original author and source are credited.
REFERENCES
1. Cuba-U.S, Building Bridges through Science and Global Health.
Symposium presentation at the 64th Annual Meeting of the
American Society of Tropical Medicine and Hygiene, October
28, 2015, Philadelphia, PA.
2. Update on Research and Control of Viral Diseases in Cuba.
Symposium presentation at the 65th Annual Meeting of the
American Society of Tropical Medicine and Hygiene, Novem-
ber 15, 2016, Atlanta, GA.
3. 3rd Workshop of Medical Virology: Challenges of the 21st
Century. December 7–9, 2016, La Habana, Cuba.
4. American Diabetes Association, 2003. Peripheral arterial disease
in people with diabetes. Diabetes Care 26: 3333–3341.
5. New York Times/CBS News telephone poll, Conducted
March 11–15, 2016. Available at: http://www.nytimes.com/
interactive/projects/cp/international/obama-in-cuba/most-
americans-support-ending-cuba-embargo-nyt-poll-finds.
6. FIU Cuban Research Institute, Florida International University,
2014. 2016 FIU Cuba Poll. How Cuban Americans in Miami
View U.S. Policies toward Cuba. Available at: https://cri.fiu.
edu/research/cuba-poll/2016-cuba-poll.pdf.
1269CUBA–UNITED STATES THAW
